ClinicalTrials.gg
RecruitingNCT07082023vnotesUpdated Jul 24, 2025

Comparison of V-NOTES and Laparoscopic Mesh-Free Sacrocolpopexy Techniques

An interventional study of V-NOTES Mesh-Free Sacrocolpopexy and Laparoscopic Mesh-Free Sacrocolpopexy in Pelvic Organ Prolapse, sponsored by Havva Betül Bacak. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-07-24.

Sponsored by Havva Betül Bacak · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Pelvic Organ Prolapse with a site in Turkey — 5 open to participants now, 6 under way, 1 of them phase 3. Pelvic Organ Prolapse · Turkey.

Planned enrollment
14th of 26
52 · median 55
Started
2025
with 4 others
No phase
25 of 40
5 open now
Registered
34th of 40
by date
Lead sponsor
3 of 40
Havva Betül Bacak

Among the 40 studies in Pelvic Organ Prolapse with a site in Turkey, this one is the 14th largest by planned enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2025, is one of 25 with no phase, and was the 34th registered.

Pelvic Organ Prolapse

522 studies on the registry are indexed under Pelvic Organ Prolapse; 81 are open to participants now.

Browse Pelvic Organ Prolapse studies →

Open to participants now

5 of the 40 studies in Pelvic Organ Prolapse with a site in Turkey are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 53 Pelvic Organ Prolapse studies recruiting now, 31 (58%) set no upper age limit and 10 (19%) stop at 75 or younger; 2 take children under 18; 14 take healthy volunteers.

This study: 18 Years to 75 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Pelvic Organ Prolapse with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to compare the surgical outcomes, safety profiles, and patient satisfaction between two minimally invasive techniques for pelvic organ prolapse repair: Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) mesh-free sacrocolpopexy and laparoscopic mesh-free sacrocolpopexy. By evaluating perioperative data, complication rates, anatomical and functional outcomes, this trial seeks to determine whether the V-NOTES approach provides comparable or superior results to the traditional laparoscopic technique, without the use of synthetic mesh.

Read the detailed description

Pelvic organ prolapse (POP) is a common condition among women, especially with increasing age and parity, often requiring surgical intervention. Sacrocolpopexy is considered the gold standard for apical prolapse repair due to its high anatomical success rate and long-term durability. Traditionally performed via open or laparoscopic approaches, sacrocolpopexy has evolved with minimally invasive techniques.

Recently, mesh-related complications have led to a growing interest in mesh-free alternatives. Simultaneously, natural orifice approaches such as Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) have gained popularity due to better cosmetic results, reduced postoperative pain, and faster recovery times.

This prospective, comparative study aims to evaluate and compare the clinical outcomes of mesh-free sacrocolpopexy performed via V-NOTES versus the laparoscopic approach. Parameters including operative time, intraoperative and postoperative complications, hospital stay, pain scores, anatomical success, and patient satisfaction will be analyzed. The goal is to assess whether V-NOTES can be a safe and effective alternative to laparoscopic mesh-free sacrocolpopexy in the surgical management of POP.

03

Conditions studied

  • Pelvic Organ Prolapse

Browse trials for

Keywords

  • Sacrocolpopexy
  • vNOTES
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who applied to Gaziosmanpaşa Education and Research Hospital, Gynecology and Obstetrics Clinic, who underwent surgery due to symptomatic pelvic organ prolapse with apical and anterior POP Q stage 2 and above, Being over 18 years old Patients who underwent surgery by experienced surgeons

Exclusion criteria

Exclusion Criteria:

  • Having previously received KT and/or RT due to any Having previously undergone surgery due to proplasus Patients with severe cardiovascular or respiratory disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    V-NOTES Sacrocolpopexy

    Patients undergoing mesh-free sacrocolpopexy via vaginal natural orifice transluminal endoscopic surgery (V-NOTES).

    Procedure: V-NOTES Mesh-Free Sacrocolpopexy

  • Active comparator
    Laparoscopic Sacrocolpopexy

    Patients undergoing mesh-free sacrocolpopexy via conventional laparoscopy.

    Procedure: Laparoscopic Mesh-Free Sacrocolpopexy

Interventions

  • ProcedureV-NOTES Mesh-Free Sacrocolpopexy

    Mesh-free sacrocolpopexy performed via vaginal natural orifice transluminal endoscopic surgery (V-NOTES).

  • ProcedureLaparoscopic Mesh-Free Sacrocolpopexy

    Mesh-free sacrocolpopexy performed via conventional laparoscopy.

06

What researchers measure

Primary outcomes

  1. Change in Pelvic Organ Prolapse Quantification (POP-Q) stage from baseline to 6 months

    Anatomical success will be evaluated using the POP-Q system. A reduction of prolapse stage by at least one level or achieving stage 0-1 will be considered successful.

    Time frame: Baseline and 6 months postoperative

  2. Change in PISQ-12 Score

    Sexual function will be evaluated with PISQ-12. An increase in score indicates improvement.

    Time frame: Baseline and 6 months postoperative

  3. Change in Pelvic Floor Distress Inventory-20 (PFDI-20) Score

    Patient-reported symptoms related to pelvic floor distress will be evaluated using the PFDI-20. A decrease in score indicates improvement in symptoms.

    Time frame: Baseline and 6 months postoperative

07

Study locations

1 of 1 sites recruiting
  • Gaziosmanpasa Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting
    • süleyman salman · Contactslymnsalman@gmail.com · +905059345470
    • yağmur md acıyiyen · Sub investigator
    • ecenur md çelikoğlu · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jan 2026, 6 months after the start.

Of 162 non-industry interventional studies with no phase under Pelvic Organ Prolapse, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 6 months is below that.

Counting every sponsor, half of 179 studies reached it within 23 months; a quarter within 12 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 4, 2025
First posted
Jul 24, 2025
StartActual
Jul 1, 2025
Primary completionEst.
Jan 1, 2026
CompletionEst.
Jan 1, 2026
Last update
Jul 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07082023
Lead sponsor
Havva Betül Bacak
Responsible party
Havva Betül Bacak (md, Gaziosmanpasa Research and Education Hospital) — Sponsor-investigator
First posted
Jul 24, 2025
Start date
Jul 1, 2025
Primary completion
Jan 1, 2026 (estimated)
Completion
Jan 1, 2026 (estimated)
Last update
Jul 24, 2025

Study contacts

ecenur çelikoğlu, md
Contact
ecenurcelikoglu14@gmail.com
+90 538 54 92 848
yağmur acıyiyen, md
Contact
yagmuraciyiyen@gmail.com
+90 542 566 9593
süleyman salman, prof
study director · Gaziosmanpaşa Training and Research Hospital
havva betül bacak, md
principal investigator · Gaziosmanpaşa Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion